Risk of overactive bladder associated with cholinesterase inhibitors in dementia.
Prajakta P MasurkarSatabdi ChatterjeeJeffrey T ShererHua ChenMichael L JohnsonRajender R AparasuPublished in: Journal of the American Geriatrics Society (2021)
The study found that the risk of OAB varies across individual ChEIs with an increased risk of OAB with donepezil compared to rivastigmine. The study findings suggest the need to understand and manage medication-related morbidity in older adults with dementia.